Highly sensitive cardiac troponin assays: A comprehensive review of their clinical utility

Cardiology in Review

Volumn 23, Issue 6, 2015, Pages 282-289

  Segraves, Justin M ^a   Frishman, William H ^b  

^a MAYO CLINIC   (United States)

^b WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

Heart failure; Highly sensitive cardiac troponins; Myocardial infarction; Prognosis; Screening

Indexed keywords

TROPONIN I; TROPONIN T; BIOLOGICAL MARKER; TROPONIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ASSAY; CLINICAL TRIAL (TOPIC); CONGESTIVE HEART FAILURE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HEART MUSCLE OXYGEN CONSUMPTION; HIGHLY SENSITIVE CARDIAC TROPONIN ASSAY; HUMAN; ISCHEMIC HEART DISEASE; OXYGEN SUPPLY; PREVALENCE; PROGNOSIS; REVIEW; ACUTE DISEASE; BIOASSAY; CHRONIC DISEASE; EARLY DIAGNOSIS; METABOLISM; MYOCARDIAL INFARCTION; PRIMARY PREVENTION; PROCEDURES;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; BIOLOGICAL ASSAY; BIOMARKERS; CHRONIC DISEASE; EARLY DIAGNOSIS; HUMANS; MYOCARDIAL INFARCTION; PRIMARY PREVENTION; PROGNOSIS; TROPONIN;

EID: 84943771835     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0000000000000087     Document Type: Review

References (29)

1. Hoyert DL, Xu J. Deaths: preliminary data for 2011. Natl Vital Stat Rep. 2012;61:1-51.
2. Gupta S, de Lemos JA. Use and misuse of cardiac troponins in clinical practice. Prog Cardiovasc Dis. 2007;50:151-165.
3. de Lemos JA. Increasingly sensitive assays for cardiac troponins: a review. JAMA. 2013;309:2262-2269.
4. Thygesen K, Alpert JS, Jaffe AS, et al; Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation. 2012;126:2020-2035.
5. Koenig W, Breitling LP, Hahmann H, et al. Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. Clin Chem. 2012;58:1215-1224.
6. Thygesen K, Mair J, Giannitsis E, et al.; Study Group on Biomarkers in Cardiology of ESC Working Group on Acute Cardiac Care. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J. 2012;33:2252-2257.
7. Wallace TW, Abdullah SM, Drazner MH, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation. 2006;113:1958-1965.
8. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009;361:868-877.
9. Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361:858-867.
10. Jancin B. Gender-specific biomarker cutoffs urged in MI diagnosis. Cardiology News 2013;11:1,9.
11. Than M, Aldous S, Lord SJ, et al. A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trial. JAMA Intern Med 2014;174:51-58.
12. Bonaca M, Scirica B, Sabatine M, et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J Am Coll Cardiol. 2010;55:2118-2124.
13. Latini R, Masson S, Anand IS, et al; Val-HeFT Investigators. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation. 2007;116:1242-1249.
14. Tsutamoto T, Kawahara C, Nishiyama K, et al. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. Am Heart J. 2010;159:63-67.
15. Kawahara C, Tsutamoto T, Nishiyama K, et al. Prognostic role of high-sensitivity cardiac troponin T in patients with nonischemic dilated cardiomyopathy. Circ J. 2011;75:656-661.
16. Kawahara C, Tsutamoto T, Sakai H, et al. Prognostic value of serial measurements of highly sensitive cardiac troponin I in stable outpatients with nonischemic chronic heart failure. Am Heart J. 2011;162:639-645.
17. Omland T, de Lemos JA, Sabatine MS, et al; Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 2009;361:2538-2547.
18. Omland T, Pfeffer MA, Solomon SD, et al; PEACE Investigators. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol. 2013;61:1240-1249.
19. Kavsak PA, Xu L, Yusuf S, et al. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin Chem. 2011;57:1146-1153.
20. McQueen MJ, Kavsak PA, Xu L, et al. Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population. Clin Biochem. 2013;46:5-9.
21. Nadir MA, Rekhraj S, Wei L, et al. Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease. J Am Coll Cardiol. 2012;60:960-968.
22. Hillis GS, Welsh P, Chalmers J, et al. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes Care. 2014;37:295-303.
23. Bandstein N, Ljung R, Johansson M, et al. Undetectable high-sensitive cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol 2014; 63: 2569-2578.
24. Eggers KM, Venge P, Lindahl B, et al. Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population. J Am Coll Cardiol. 2013;61:1906-1913.
25. Daniels LB. The enemy of good? making the most of highly sensitive troponin assays. J Am Coll Cardiol. 2013;61:1914-1916.
26. Chatterjee S, Kim J, Dahhan A, et al. Use of high-sensitivity troponin assays predicts mortality in patients with normal conventional troponin assays on admission-insights from a meta-analysis. Clin Cardiol. 2013;36:649-653.
27. Sara JD, Holmes DR Jr, Jaffe AS. Fundamental concepts of effective troponin use: important principles for internists. Am J Med. 2015;128:111-119.
28. Everett BM, Brooks MM, Vlachos HE, et al. BARI 2D Study Group. Troponin and cardiac events in stable ischemic heart disease and diabetes. N Engl J Med 2015;373:610-620.
29. Melloni C, Roe MT. Cardiac troponin and risk stratification in ischemic heart disease (editorial). N Engl J Med 2015;373:672-674.